We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Organoids in Industry: Disease Modeling Platforms To Accelerate Drug Discovery

In this Teach Me in 10 episode, we're joined by Dr. Rebecca Warfield, a Field Application Scientist from ACROBiosystems, to explore the pivotal role of organoids as disease modeling platforms and how ACROBiosystems' solutions support their integration into the pharmaceutical landscape, ultimately speeding up drug development.

Organoids are essential tools in this realm, providing highly accurate representations of diseases that significantly advance pharmaceutical research and streamline drug development processes. By closely mimicking human organ structure and function, organoids enable precise disease modeling, enhancing tasks like drug screening, toxicity assessment, and personalized medicine initiatives. This capability is crucial for translating preclinical findings into clinically relevant applications, facilitating the swift identification of therapeutic compounds.

As the scale of both preclinical and clinical studies increases, the importance of utilizing consistent and application-validated organoids grows, ensuring that research findings can efficiently transition into impactful clinical therapies.

Further Resources:

Brought to you by